|
In global clinical trials, Johnson & Johnson's
single-dose coronavirus vaccine proved to be 66 percent effective in
preventing moderate to severe cases of COVID-19. The drugmaker plans to apply
for emergency use authorization in the U.S. next week. Get the
latest news on COVID-19 vaccines.
|
No comments:
Post a Comment